ArticleJournal of biological engineering2026
High-titer 2-phenylethanol production in Escherichia coli via decarboxylation-step optimization and a vegetable-oil overlay for biocompatible in situ recovery.
Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
background2-phenylethanol (2-PE) is a high-value aromatic alcohol. Its bioproduction is limited by pathway bottlenecks, limited by a rate-limiting decarboxylation step, product toxicity, and volatilization. We sought to build an efficient Escherichia coli (E. coli) platform by optimizing the segment of the Ehrlich route that converts L-phenylalanine (L-Phe) to 2-PE, together with a food-grade soybean-oil overlay for in situ product recovery (ISPR).
resultsWhole-cell assays showed that phenylpyruvate decarboxylation was the main bottleneck when the yeast decarboxylase Aro10 was used. A phylogeny-guided screen identified Lactococcus lactis KivD as a superior substitute in E. coli. After replacing Aro10 with KivD and tuning expression, leveraging endogenous glutamate dehydrogenase (GDH) for NAD(P)H recycling enabled sufficient cofactor regeneration, yielding 49.5 mM 2-PE from 50 mM L-Phe with 99.0% conversion. At the shake-flask scale, a fed-batch L-Phe feeding strategy coupled with a 2:1 soybean-oil overlay for in situ product removal reduced toxicity and volatilization losses, producing 130 mM 2-PE (15.9 g/L). Using soybean oil as an ISPR phase effectively sequestered 2-PE from the aqueous phase, minimizing volatilization and increasing the overall recovered yield to 94.2% based on L-Phe consumption.
conclusionsReplacing the rate-limiting decarboxylation step with KivD, balancing redox through cofactor recycling, and coupling the pathway to a mild oil-overlay recovery increased flux and enabled high-titer 2-PE in E. coli. The workflow of bottleneck substitution plus biocompatible in situ recovery can be transferred to related aromatic alcohols and provides a foundation for de novo routes and high-cell-density fermentations that target still higher titers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.